Immunovant, Inc. (IMVT)
32.84
-0.46
(-1.38%)
USD |
NASDAQ |
Jun 01, 16:00
32.84
0.00 (0.00%)
After-Hours: 20:00
Immunovant Market Cap : 6.742B for June 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roivant Sciences Ltd. | 20.92B |
| Catalyst Pharmaceuticals, Inc. | 3.827B |
| Summit Therapeutics, Inc. | 12.19B |
| Protagonist Therapeutics, Inc. | 6.098B |
| UroGen Pharma Ltd. | 1.319B |
Market Cap Related Metrics
| PEG Ratio | -9.714 |
| Price to Book Value | 7.908 |
| Price | 32.84 |
| Earnings Yield | -8.43% |
| PEGY Ratio | -9.714 |